Kardalas, E.; Maraka, S.; Papagianni, M.; Paltoglou, G.; Siristatidis, C.; Mastorakos, G.
TGF-β Physiology as a Novel Therapeutic Target Regarding Autoimmune Thyroid Diseases: Where Do We Stand and What to Expect. Medicina 2021, 57, 621.
https://doi.org/10.3390/medicina57060621
AMA Style
Kardalas E, Maraka S, Papagianni M, Paltoglou G, Siristatidis C, Mastorakos G.
TGF-β Physiology as a Novel Therapeutic Target Regarding Autoimmune Thyroid Diseases: Where Do We Stand and What to Expect. Medicina. 2021; 57(6):621.
https://doi.org/10.3390/medicina57060621
Chicago/Turabian Style
Kardalas, Efstratios, Spyridoula Maraka, Maria Papagianni, George Paltoglou, Charalampos Siristatidis, and George Mastorakos.
2021. "TGF-β Physiology as a Novel Therapeutic Target Regarding Autoimmune Thyroid Diseases: Where Do We Stand and What to Expect" Medicina 57, no. 6: 621.
https://doi.org/10.3390/medicina57060621
APA Style
Kardalas, E., Maraka, S., Papagianni, M., Paltoglou, G., Siristatidis, C., & Mastorakos, G.
(2021). TGF-β Physiology as a Novel Therapeutic Target Regarding Autoimmune Thyroid Diseases: Where Do We Stand and What to Expect. Medicina, 57(6), 621.
https://doi.org/10.3390/medicina57060621